Delivery Order SPE2DX15D2011-SPE2DX22F17AE

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 17, 2026, for ProQuad Vials in quantities of 10 units, with a ceiling value of $3,792.70 and an ultimate completion date of February 5, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a task order...

The Defense Logistics Agency awarded a delivery order valued at $1,674.25 to AmerisourceBergen Drug Corp for ProQuad vials on January 29, 2026, with an ultimate completion date of February 20, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, commonly used across military healthcare...

The Defense Logistics Agency awarded a delivery order valued at $4,288.89 to AmerisourceBergen Drug Corp for ProQuad vials on November 26, 2025, with completion required by December 18, 2025. This is a firm fixed-price, non-set-aside contract performed at the awardee's location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, commonly used in military medical readiness and vaccination programs. This delivery order...

The Defense Logistics Agency awarded a delivery order valued at $1,670.90 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of October 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, indicating this delivery order supports federal immunization requirements for military and defense personnel. AmerisourceBergen Drug Corp, a major...

The Defense Logistics Agency awarded a $7,963.05 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for ProQuad vials, with an ultimate completion date of December 26, 2025. This is a firm fixed-price contract with no set-aside designation, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to immunize against measles, mumps, rubella, and varicella, making this order part of the federal government's medical...

The Defense Logistics Agency awarded a delivery order valued at $33,749.60 to AmerisourceBergen Drug Corp for ProQuad vials on September 16, 2025, with a completion date of October 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to immunize against measles, mumps, rubella, and varicella, making this award part of DLA's critical medical...

The Defense Logistics Agency awarded a delivery order valued at $5,062.44 to AmerisourceBergen Drug Corp for ProQuad vials on August 18, 2025, with a completion date of September 9, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, commonly used within military and...

The Defense Logistics Agency awarded a delivery order valued at $3,374.88 to AmerisourceBergen Drug Corp for ProQuad vials on September 17, 2025, with completion expected by October 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for ProQuad vials valued at $8,221.20, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to immunize against measles, mumps, rubella, and varicella, representing a critical...

The Defense Logistics Agency awarded a delivery order valued at $3,269.34 to AmerisourceBergen Drug Corp for ProQuad vials on November 5, 2025, with an ultimate completion date of November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the vendor's corporate office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine that provides immunization protection against measles, mumps, rubella, and varicella, making it a critical...